Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome.
J Clin Lipidol
; 15(6): 789-792, 2021.
Article
em En
| MEDLINE
| ID: mdl-34600840
ABSTRACT
We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who developed rhabdomyolysis and acute kidney injury, two weeks after switching from lovastatin to rosuvastatin. She had been on lovastatin for eight years without any adverse effects.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Rabdomiólise
/
Anormalidades Múltiplas
/
Rosuvastatina Cálcica
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Estados Unidos